{"id":"NCT02493946","sponsor":"Ipsen","briefTitle":"Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines","officialTitle":"Phase III, Randomised, Double Blind, Placebo Controlled and Open Label Phase Multicentre Study to Investigate the Efficacy and Safety of BTX-A-HAC NG in the Treatment of Moderate to Severe Glabellar Lines, and Assess the Long Term Efficacy and Safety of BTX-A-HAC NG Following Repeated Treatments in This Indication","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-04","primaryCompletion":"2015-10","completion":"2016-12","firstPosted":"2015-07-10","resultsPosted":"2019-05-28","lastUpdate":"2022-09-28"},"enrollment":600,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glabellar Lines"],"interventions":[{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["BTX-A-HAC NG"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BTX-A-HAC NG","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the protocol is to demonstrate the safety and the efficacy of a single injection of a new formulation of Clostridium Botulinum toxin type A haemagglutinin complex (BTX A HAC NG) to improve the appearance of moderate to severe glabellar lines (the lines between the eyebrows) and to assess the long term efficacy and safety of BTX-A-HAC NG after repeated injections.","primaryOutcome":{"measure":"The Percentage of Responders at Day 29 Cycle 1 as Measured by Investigator's Live Assessment (ILA) of Glabellar Lines at Maximum Frown: DB Period","timeFrame":"Day 29 (Cycle 1)","effectByArm":[{"arm":"BTX-A-HAC Solution 50 U - DB Period","deltaMin":81.6,"sd":null},{"arm":"Placebo - DB Period","deltaMin":0.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":24,"countries":["France","Germany","United Kingdom"]},"refs":{"pmids":["36206385"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":126},"commonTop":["Nasopharyngitis","Headache","Back pain","Bronchitis","Sinusitis"]}}